Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 25:12:1581597.
doi: 10.3389/fmed.2025.1581597. eCollection 2025.

Neuronal ceroid lipofuscinosis type 5 in Russia: first case report and literature review

Affiliations
Case Reports

Neuronal ceroid lipofuscinosis type 5 in Russia: first case report and literature review

Olga P Parshina et al. Front Med (Lausanne). .

Abstract

Neuronal ceroid lipofuscinosis (NCL) is one of the most common causes of childhood dementia. NCL type 5 is characterized by epileptic seizures, cognitive decline, and progressive vision loss. Whole exome sequencing was performed, and the identified variant was confirmed by Sanger sequencing. Despite various therapeutic regimens, including novel approaches, seizure control could not be achieved. The disease was caused by a previously undescribed pathogenic variant CLN5(NM_006493.4):c.368del (p.Arg123LysfsTer4). This is the first known case of NCL type 5 in Russia. Unusually, the patient also had a cervical lymphangioma requiring separate medical and surgical intervention. This case report contributes to our understanding of the natural history of CLN5-associated NCL and may support the development of gene therapy approaches for its treatment.

Keywords: CLN5; epilepsy; neurodegenerative disease; neuronal ceroid lipofuscinosis; next-generation sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Axial T2-weighted slice demonstrates excessive widening of cerebellar sulci and expansion of cisternal spaces in the posterior cranial fossa, reflecting moderate cerebellar atrophic volume loss. (B) Axial T2 FLAIR slice reveals mild periventricular leukoencephalopathy in the white matter of the frontal and parietal lobes. (C) Sagittal T1-weighted slice shows reduced cerebellar volume with an enlarged posterior cranial fossa, clearly illustrating cerebellar atrophy.
Figure 2
Figure 2
Magnetic resonance imaging of the patient’s brain performed in 7 years 6 months ago.
Figure 3
Figure 3
(A) Electroencephalography (EEG) during wakefulness (age 7 years and 6 months). Parameters: speed = 30 mm/s, sensitivity = 10 μV/mm, high-frequency filter = 0.5 Hz, low-frequency filter = 70 Hz, notch filter = 50 Hz, bipolar longitudinal montage. (B) EEG during daytime sleep (age 7 years and 6 months). Parameters: speed = 30 mm/s, sensitivity = 10 μV/mm, low-frequency filter (LFF) = 0.5 Hz, high-frequency filter (HFF) = 70 Hz, notch filter = 50 Hz, bipolar longitudinal montage.
Figure 4
Figure 4
(A) Sanger sequencing results in the nuclear family, (B) Pedigree of the proband, (C) Distribution of variants in the CLN5 gene by type, dup – duplication.

References

    1. Huber RJ, Hughes SM, Liu W, Morgan A, Tuxworth RI, Russell C. The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research. Biochim Biophys Acta Mol basis Dis. (2020) 1866:165614. doi: 10.1016/j.bbadis.2019.165614, PMID: - DOI - PubMed
    1. Trivisano M, Ferretti A, Calabrese C, Pietrafusa N, Piscitello L, Carfi’ Pavia G, et al. Neurophysiological findings in neuronal ceroid lipofuscinoses. Front Neurol. (2022) 13:845877. doi: 10.3389/fneur.2022.845877, PMID: - DOI - PMC - PubMed
    1. Kozina AA, Okuneva EG, Baryshnikova NV, Kondakova OB, Nikolaeva EA, Fedoniuk ID, et al. Neuronal ceroid lipofuscinosis in the Russian population: two novel mutations and the prevalence of heterozygous carriers. Mol Genet Genomic Med. (2020) 8:e1228. doi: 10.1002/mgg3.1228, PMID: - DOI - PMC - PubMed
    1. Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Kleine Holthaus SM, et al. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol. (2019) 18:107–16. doi: 10.1016/S1474-4422(18)30368-5, PMID: - DOI - PubMed
    1. Kaminiów K, Kozak S, Paprocka J. Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid Lipofuscinosis. Int J Mol Sci. (2022) 23:5729. doi: 10.3390/ijms23105729, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources